BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 870426)

  • 1. Antibody to Corynebacterium parvum in normal human and animal sera.
    Wolberg G; Duncan GS; Adlam C; Whisnant JK
    Infect Immun; 1977 Mar; 15(3):1004-7. PubMed ID: 870426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Corynebacterium parvum on the immune response in guinea pigs. I. Mode of enhancement of the anamnestic response and development of delayted hypersensitivity after treatment with Corynebacterium parvum].
    Halpern B; Gauthier-Rahman S; Besluau D
    C R Seances Soc Biol Fil; 1977; 171(6):1202-8. PubMed ID: 148948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the classical and alternate pathways of complement by Corynebacterium parvum.
    McBride WH; Weir DM; Kay AB; Pearce D; Caldwell JR
    Clin Exp Immunol; 1975 Jan; 19(1):143-7. PubMed ID: 1204238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corynebacterium parvum: antibodies measured with the enzyme-linked immunosorbent assay (ELISA) in normal human sera and sera from cancer patients undergoing treatment.
    Ruitenberg EJ; Buys J; Ursem PS
    Ann Immunol (Paris); 1982; 133D(3):305-11. PubMed ID: 7165281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of Corynebacterium parvum on the immune response in guinea pigs. II. Passive transfer of enhanced anamnestic response and delayed hypersensitivity observed after treatment with Corynebacterium parvum].
    Halpern B; Gauthier-Rahman S; Besluau D
    C R Seances Soc Biol Fil; 1977; 171(6):1209-16. PubMed ID: 148949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corynebacterium parvum antibodies in healthy and cancer patients.
    Hardas U; Jalgaonkar SV; Chatterjee AK
    Indian J Cancer; 1982; 19(2):113-5. PubMed ID: 7129515
    [No Abstract]   [Full Text] [Related]  

  • 7. [The bacteriological and biological significance of Propionibacterium acnes--the indigenous bacteria of human skin. IV. Age-related change in antibody to P. acnes in normal human sera (author's transl)].
    Kishishita M; Ushijima T; Ozaki Y
    Nihon Hifuka Gakkai Zasshi; 1979 Oct; 89(11):761-5. PubMed ID: 316030
    [No Abstract]   [Full Text] [Related]  

  • 8. Proliferative glomerulonephritis in mice given intravenous Corynebacterium parvum.
    Uff JS; Mitcheson HD; Pussell BA; Brill M; Castro JE
    J Pathol; 1981 Feb; 133(2):89-105. PubMed ID: 6451676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
    Woodruff MF; McBride WH; Dunbar N
    Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrosoluble immunopotentiating substances extraced from Corynebacterium parvum.
    Migliore-Samour D; Korontzis M; Jollès P
    Immunol Commun; 1974; 3(6):593-603. PubMed ID: 4217774
    [No Abstract]   [Full Text] [Related]  

  • 11. Potentiation of anamnestic humoral responses by a single intravenous injection of Corynebacterium parvum (C. parvum) in adult rabbits.
    Parlebas J; Halpern B
    Dev Biol Stand; 1977 Apr 13-15; 38():201-4. PubMed ID: 608507
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunomodulation by corynebacterium parvum in two strains of guinea-pigs and the effect of cyclophosphamide.
    Gauthier-Rahman S
    Immunology; 1981 Jan; 42(1):99-109. PubMed ID: 7461727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental otitis media in guinea pigs. Serum antibody response to Bacteroides fragilis, Propionibacterium acnes and Peptostreptococcus anaerobius upon challenge.
    Thore M
    Acta Otolaryngol Suppl; 1984; 414():143-6. PubMed ID: 6598260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Corynebacterium parvum on the immune response of the guinea pig to ovalbumin.
    Gauthier-Rahman S; Halpern B; Besluau D
    Dev Biol Stand; 1977 Apr 13-15; 38():205-14. PubMed ID: 608508
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical and immunological studies on the cell walls of Propionibacterium acnes strain C7 and Corynebacterium parvum ATCC 11829.
    Azuma I; Sugimura K; Taniyama T; Aladin A; Yamamura Y
    Jpn J Microbiol; 1975 Aug; 19(4):265-75. PubMed ID: 811835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Corynebacterium parvum with Freund's complete adjuvant as a potentiator of the immune response to beta-human chorionic gonadotropin linked to tetanus toxoid.
    Covey DC; Laurence KA
    Am J Reprod Immunol (1980); 1984; 5(3):114-6. PubMed ID: 6588767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the Corynebacterium parvum-associated anaemia in mice.
    Cox KO; Keast D
    Clin Exp Immunol; 1974 May; 17(1):199-207. PubMed ID: 4466596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of inhibition by Corynebacterium parvum of the growth of lung nodules from intravenously injected tumour cells.
    Bomford R; Olivotto M
    Int J Cancer; 1974 Aug; 14(2):226-35. PubMed ID: 4376512
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunopotentiation of cell-mediated hypersensitivity by Corynebacterium parvum (Propionibacterium acnes).
    Maguire HC; Cipriano D
    Int Arch Allergy Appl Immunol; 1983; 70(1):34-9. PubMed ID: 6848475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pulmonary clearance of Pasteurella haemolytica in calves given Corynebacterium parvum and infected with parainfluenza-3 virus.
    Al-Izzi SA; Maxie MG; Savan M
    Can J Comp Med; 1982 Jan; 46(1):85-90. PubMed ID: 6280824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.